medigraphic.com

2009, Number 5

<< Back Next >>

Rev Fac Med UNAM 2009; 52 (5)

Anti-inflammatory non steroidal drug on the treatment of arterial hypertension

Hernando R, José Rodríguez J

Language: Spanish
References: 26
Page: 227-229
PDF size: 32.53 Kb.


ABSTRACT

Background: Clinical observations suggest that the regular use of aspirin reduce the risk of ischemic stroke and Parkinson´s disease. Methods: We report the use of aspirin and clonazepam into two patients with essential arterial hypertension (EAH) and aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) in a woman with type 2 diabetes mellitus (type 2 DM). Case report: Case 1, is a 65-year-old man with history of EAH, which was treated with captopril. On July 2000, he received aspirin and clonazepam as supplementary medication. Four years later, his blood pressure was normalized without antihypertensive medication. Case 2, was a 75-year-old woman who suffered of type 2 DM between 45 to 60 years of age. Moreover, since 55 to 75 years, she presented osteoarthritis. So then, since 55 to 60 years she received antidiabetic treatment, aspirin and NSAIDs. After 60 years of age, her glycemias were normal and without antidiabetic therapy. Case 3, is a 62-year-old woman who suffered from stress, sleep disorders and EAH, since ten years before her admission. From the first, she received only aspirin and clonazepam. At present, 11 months later, her blood pressure is normal. Conclusion: These clinical observations suggest that the regular use of aspirin may improve or normalize EAH and type 2 DM.


REFERENCES

  1. Rafael H. Rejuvenation after omental transplantation on the optic chiasma and carotid bifurcation. Case Rep Clin Prac Rev 2006; 7: 48-51. www.amjcaserep.com

  2. Rafael H. Hypothalamic ischemia and premature aging. Med Sci Monit 2007; 13(7): LE9-10. www.medscimonit.com

  3. Rafael H, Mego R, Moromizato P, García W, Rodriguez J. Omental transplantation for type 2 diabetes mellitus. A report of two cases. Case Rep Clin Pract Rev 2004; 5: 481-86.

  4. Rafael H. Isquemia hipotalámica y diabetes mellitus tipo 2. Rev Mex Cardiol 2007; 18(4): 185-187. www.medigraphic.com

  5. Rafael H. Cerebral atherosclerosis and oxidative stress in some challenging diseases. J Neurol Sci (Turk) 2004; 21(4): 343-349. www.jns.dergisi.org

  6. Flora GC, Baker AB, Loewenson RB, Klassen AC. A comparative study of cerebral atherosclerosis in males and females. Circulation 1968; 38: 859-869.

  7. Hass K, Fields WS, North RR, Krichefff H, Chase NE, Bauer RB. Joint study of extracranial arterial occlusion II: arteriography, techniques, sites, and complications. JAMA 1968; 203: 961-968.

  8. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340: 115-126.

  9. Patrono C, García LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005; 353: 2373-2383.

  10. Corman SI, Fedutes BA, Ansani NT. Impact of nonsteroidal anti-inflammatory drugs on the cardioprotective effects of aspirin. Ann Pharmacother 2005; 39: 1073-79.

  11. Wahner AD, Bronstein JM, Bordelon YD, Ritz B. Nonsteroidal anti-inflammatory drugs may protect against Parkinson´s disease. Neurology 2007; 69: 1836-42.

  12. Li Z-G, Yu Z-C, Wang D-Z et al. Influence of acetylsalicylate on plasma lysophosphatidic acid level in patients with ischemic cerebral vascular. Neurol Res 2008; 30: 366-69.

  13. Diener HC, Cunha L, Forbes C, Sivenius J, Smet P, Lowenthal A. European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.

  14. Rafael H, Correa F, Moromizato P, Espinoza M. Hipertensión esencial y trasplante de epiplón al espacio perforado anterior. Hipertensión (Méx ) 1999; 19(3): 42-45.

  15. Rafael H. Neurogenic hypertension. J Neurosurg 2003; 99: 1117-1118 (letter ).

  16. Goldsmith HS (ed). The omentum; Application to brain and spinal cord. Walton CT, Forefront Publ 2000.

  17. Rafael H. El epiplón: Trasplante al sistema nervioso. México, D.F. Editorial Prado 1996.

  18. García-Gómez I, Goldsmith HS, Angulo J et al. Angiogenic capacity of human stem cells. Neurol Res 2005; 27(8): 807-811.

  19. Rafael H. Aplicación clínica del epiplón en el sistema nervioso central. Acta Méd Per 2008; 25(3): 176-180. www.cmp.org.pe/actamedica

  20. Rafael H. Hypothalamic ischemia and metabolic syndrome. Med Sci Monit 2006; 12(8): LE17-18. www.medscimonit.com

  21. Rafael H, Morales A. Anormalidades del ritmo cardíaco y lóbulo temporal medial. Hipertensión (Méx ) 2003; 24(9): 11-13.

  22. Rafael H. Omental transplantation for epilepsy. J Neurosurg 2001; 95(9): 543-44 (letter ).

  23. Enna SJ. GABA receptors TIPS 1981; 2(3): 62-64.

  24. Rafael H, Valadez MT. Disfunción cerebral mínima III: Tratamiento (reporte preliminar). Salud Publ Méx 1987; 29: 55-60.

  25. Malow BA. Sleep and epilepsy. Neurologic Clinic 1996; 14: 765-789.

  26. Rafael H, Mego R, Moromizato P, García W. Omental transplantation for temporal lobe epilepsy: Report of two cases. Neurol India 2002; 50: 71-74. www.neurologyindia.com.




2020     |     www.medigraphic.com